Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC
22 May 2023
 

FORM 8.3 Amendment to Sale and Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.0001 ordinary shares

Date of dealing

15 May 2023

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.0001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

1,306,390

0.57%

480,578

0.21%

(2)

Derivatives (other than options):

53,580

0.02%

0

0.00%

(3)

Options and agreements to purchase/sell:

1,532,700

0.67%

1,379,500

0.60%

TOTAL:

2,892,670

1.27%

1,860,078

0.81%

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

$0.0001 ordinary shares

Purchase

3

                 111.4800 USD

$0.0001 ordinary shares

Purchase

4

                 112.1300 USD

$0.0001 ordinary shares

Purchase

17

                 111.6200 USD

$0.0001 ordinary shares

Purchase

29

                 111.6300 USD

$0.0001 ordinary shares

Purchase

100

                 112.2660 USD

$0.0001 ordinary shares

Purchase

100

                 112.2600 USD

$0.0001 ordinary shares

Purchase

191

                 112.2289 USD

$0.0001 ordinary shares

Purchase

200

                 111.5750 USD

$0.0001 ordinary shares

Purchase

200

                 112.0500 USD

$0.0001 ordinary shares

Purchase

200

                 112.2790 USD

$0.0001 ordinary shares

Purchase

201

                 112.2700 USD

$0.0001 ordinary shares

Purchase

306

                 111.5628 USD

$0.0001 ordinary shares

Purchase

400

                 112.2825 USD

$0.0001 ordinary shares

Purchase

415

                 112.0316 USD

$0.0001 ordinary shares

Purchase

520

                 111.7746 USD

$0.0001 ordinary shares

Purchase

544

                 112.0680 USD

$0.0001 ordinary shares

Purchase

548

                 111.5766 USD

$0.0001 ordinary shares

Purchase

606

                 112.1875 USD

$0.0001 ordinary shares

Purchase

1,215

                 112.2685 USD

$0.0001 ordinary shares

Purchase

1,626

                 111.7197 USD

$0.0001 ordinary shares

Purchase

3,360

                 111.5974 USD

$0.0001 ordinary shares

Purchase

5,000

                 111.0762 USD

$0.0001 ordinary shares

Purchase

5,000

                 111.5462 USD

$0.0001 ordinary shares

Purchase

5,316

                 112.3385 USD

$0.0001 ordinary shares

Purchase

6,057

                 112.1042 USD

$0.0001 ordinary shares

Purchase

6,329

                 112.2495 USD

$0.0001 ordinary shares

Purchase

8,183

                 111.7324 USD

$0.0001 ordinary shares

Purchase

8,344

                 112.0643 USD

$0.0001 ordinary shares

Purchase

12,500

                 111.9624 USD

$0.0001 ordinary shares

Purchase

23,851

                 112.2500 USD

$0.0001 ordinary shares

Purchase

24,643

                 112.0127 USD

$0.0001 ordinary shares

Purchase

25,946

                 112.0447 USD

$0.0001 ordinary shares

Purchase

29,574

                 112.0229 USD

$0.0001 ordinary shares

Sale

2

                 111.9200 USD

$0.0001 ordinary shares

Sale

40

                 111.8005 USD

$0.0001 ordinary shares

Sale

73

                 112.1600 USD

$0.0001 ordinary shares

Sale

100

                 111.7900 USD

$0.0001 ordinary shares

Sale

100

                 111.8900 USD

$0.0001 ordinary shares

Sale

100

                 112.2700 USD

$0.0001 ordinary shares

Sale

100

                 111.4400 USD

$0.0001 ordinary shares

Sale

114

                 112.2617 USD

$0.0001 ordinary shares

Sale

200

                 111.9100 USD

$0.0001 ordinary shares

Sale

201

                 112.2102 USD

$0.0001 ordinary shares

Sale

300

                 111.5266 USD

$0.0001 ordinary shares

Sale

400

                 111.8150 USD

$0.0001 ordinary shares

Sale

400

                 111.7100 USD

$0.0001 ordinary shares

Sale

401

                 112.1660 USD

$0.0001 ordinary shares

Sale

493

                 111.6880 USD

$0.0001 ordinary shares

Sale

502

                 112.0343 USD

$0.0001 ordinary shares

Sale

509

                 112.0590 USD

$0.0001 ordinary shares

Sale

600

                 111.6400 USD

$0.0001 ordinary shares

Sale

700

                 111.5728 USD

$0.0001 ordinary shares

Sale

700

                 111.8500 USD

$0.0001 ordinary shares

Sale

709

                 112.0830 USD

$0.0001 ordinary shares

Sale

907

                 112.1188 USD

$0.0001 ordinary shares

Sale

1,000

                 111.5527 USD

$0.0001 ordinary shares

Sale

1,100

                 111.6931 USD

$0.0001 ordinary shares

Sale

1,364

                 112.1223 USD

$0.0001 ordinary shares

Sale

2,290

                 111.8987 USD

$0.0001 ordinary shares

Sale

2,472

                 112.2500 USD

$0.0001 ordinary shares

Sale

3,081

                 111.9482 USD

$0.0001 ordinary shares

Sale

3,082

                 112.0358 USD

$0.0001 ordinary shares

Sale

4,681

                 112.1023 USD

$0.0001 ordinary shares

Sale

8,216

                 112.1176 USD

$0.0001 ordinary shares

Sale

10,388

                 112.2494 USD

$0.0001 ordinary shares

Sale

12,500

                 111.9613 USD

$0.0001 ordinary shares

Sale

12,500

                 111.9624 USD

$0.0001 ordinary shares

Sale

13,687

                 112.0459 USD

$0.0001 ordinary shares

Sale

14,500

                 108.8086 USD

$0.0001 ordinary shares

Sale

15,493

                 112.0394 USD

$0.0001 ordinary shares

Sale

16,266

                 112.2499 USD

$0.0001 ordinary shares

Sale

19,925

                 112.0146 USD

$0.0001 ordinary shares

Sale

30,705

                 111.9525 USD

 

 








(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

$0.0001 ordinary shares

Put Options

Selling

1,400

                 105.0000 USD

American

12 May 2023

                   0.3000 USD

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit

 (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing  and any other person relating to the voting rights of any relevant securities under any option  referred to on this form or relating to the voting rights or future acquisition or disposal of any  relevant securities to which any derivative referred to on this form is referenced. If none, this  should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

19-May-23

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 








SUPPLEMENTAL FORM 8

 








IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

OPEN POSITIONS

 







Class of relevant

 security

Product

 Description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

$0.0001 ordinary shares

Put Options

Written

495,500

100

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Written

150,000

090

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-67,300

110

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-65,000

095

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-25,000

085

American

19 May 2023

$0.0001 ordinary shares

Put Options

Purchased

-250,000

080

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Written

250,000

105

American

16 Jun 2023

$0.0001 ordinary shares

Put Options

Written

10,200

080

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Written

65,000

105

American

19 May 2023

$0.0001 ordinary shares

Put Options

Written

400,000

100

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Purchased

-800,000

080

American

18 Aug 2023

$0.0001 ordinary shares

Put Options

Written

162,000

105

American

21 Jul 2023

$0.0001 ordinary shares

Put Options

Purchased

-162,000

090

American

21 Jul 2023

$0.0001 ordinary shares

Put Options

Purchased

-10,200

100

American

18 Aug 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings